Skip to content

Clinical trials

Myocardial Infarction trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Country / region: Czechia Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20051
20065
20072
20082
20093
20103
20113
20137
20144
20152
20163
20192
20201
20222
20234
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated7
Recruiting5
Active, not recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Charles University, Czech Republic3
Novartis3
AstraZeneca2
Bayer2
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Pfizer2
University Hospital Pilsen2
Abcentra1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction53
Stroke14
Cardiovascular Diseases11
Acute Coronary Syndrome9
Coronary Artery Disease8
Myocardial Ischemia7
Heart Diseases6
Angina, Unstable5
Heart Failure5
ST Elevation Myocardial Infarction4

Trials

Showing 51 to 53 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.